Yasons Chemex Care Board of Directors

Get the latest insights into the leadership at Yasons Chemex Care. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Pritesh Yashwantlal Shah Chairman & Managing Director
Ms. Dimple Priteshkumar Shah Whole Time Director
Ms. Angee Rajendrakumar Shah Independent Director
Ms. Silva Kriyangbhai Shah Independent Director
Mr. Rushabh Anilkumar Shah Independent Director

Yasons Chemex Care Share price

YCCL

12.3

0.25 (2.07%)
NSE
BSE
Last updated on 29 Aug, 2025 | 14:40 IST
BUYSELL
Today's High

12.30

Today's Low

12.25

52 Week Low

11.80

52 Week High

24.40

The current prices are delayed, login to your account for live prices

Yasons Chemex Care FAQs

The board at Yasons Chemex Care consists of experienced professionals, including Mr. Pritesh Yashwantlal Shah , Ms. Dimple Priteshkumar Shah , and others, overseeing the company’s strategic and corporate governance.

Directors at Yasons Chemex Care are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Pritesh Yashwantlal Shah is the current chairman at Yasons Chemex Care.

Executive directors at Yasons Chemex Care are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Yasons Chemex Care adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Yasons Chemex Care, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.